Max Robotics — Global Service Robot Directory + US Certification

About

Steven A. Kaplan is a leading urologist whose research has fundamentally advanced the surgical treatment of benign prostatic hyperplasia (BPH), particularly for patients with large prostates (80–150 cc). His seminal work on Aquablation therapy—a minimally invasive, heat-free waterjet ablation technique—has redefined surgical options for men with lower urinary tract symptoms (LUTS) who previously faced limited choices beyond open prostatectomy. Kaplan’s landmark 2019 study reporting 1-year Aquablation results in large prostates (63 citations) demonstrated the procedure’s safety and efficacy, with subsequent 2-year follow-up (24 citations) confirming durable outcomes. His comparative analysis of the WATER and WATER II trials (2021, 25 citations) provided critical evidence that Aquablation is effective across prostate sizes, while his meta-analysis (14 citations) synthesized individual patient data to validate functional outcomes in diverse anatomies. Kaplan also pioneered research on Aquablation in elderly men (16 citations), expanding treatment access for vulnerable populations. His 4-year real-world data (9 citations) from the largest single-center study underscores the procedure’s long-term reliability. With over 150 cumulative citations on these core papers, Kaplan’s contributions have directly shaped clinical guidelines and offered a transformative, less invasive alternative for patients with complex BPH.